#ThroughTheGenes is an informative podcast highlighting the risks, benefits, and limitations of gene- and cell-based therapies as curative options for sickle cell disease. The show is hosted by sickle sisters Wunmi Bakare and Dima Hendricks. It takes you behind the lived experience of patients who participated in the curative process, revealing their highs, lows, and everything in between.
This collaborative effort aims to help patients and their support networks navigate emerging developments in gene therapies for sickle cell disease.
All content for #ThroughTheGenes is the property of #ThroughTheGenes and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
#ThroughTheGenes is an informative podcast highlighting the risks, benefits, and limitations of gene- and cell-based therapies as curative options for sickle cell disease. The show is hosted by sickle sisters Wunmi Bakare and Dima Hendricks. It takes you behind the lived experience of patients who participated in the curative process, revealing their highs, lows, and everything in between.
This collaborative effort aims to help patients and their support networks navigate emerging developments in gene therapies for sickle cell disease.
To conclude our discussion on the topic "What Happens To The Body In Gene Therapy", our hosts - Wunmi Bakare and Christelle Salomon - sat down with Dr. Elizabeth Krieger, who is a pediatric hematologist-oncologist specializing in bone marrow transplant and cellular therapies. Discover why chemotherapy is carried out for these therapies, the side effects of chemotherapy, and why some protocols require radiation and others do not.
#ThroughTheGenes #TTGS2 #TTGPodcast #GeneTherapy #TTGxBeam #TTGxSynthego #TTGxUCSF #TTGxSCP #SickleCellDisease #TransformativeTherapiesForSickleCell #SickleCellAwareness #SickleCellEducation
#ThroughTheGenes
#ThroughTheGenes is an informative podcast highlighting the risks, benefits, and limitations of gene- and cell-based therapies as curative options for sickle cell disease. The show is hosted by sickle sisters Wunmi Bakare and Dima Hendricks. It takes you behind the lived experience of patients who participated in the curative process, revealing their highs, lows, and everything in between.
This collaborative effort aims to help patients and their support networks navigate emerging developments in gene therapies for sickle cell disease.
